Cornelia brings extensive experience in phenotypic screening projects and the implementation of lab automation platforms across prestigious biomedical academic institutes, pharmaceutical, and biotech companies in Switzerland, Denmark, Sweden, and Germany. Currently, she is leading the lab automation efforts at PMI Life Science Laboratories, where she oversees a multi-disciplinary team in optimizing biological workflows, automating processes, and integrating and validating data flows.
Safety assessment of consumer products is crucial to product life cycle and development, governed by OECD guidelines and performed under stringent GLP conditions. Traditionally, validated methods and protocols are performed manually, which is challenging during high demand. Automation offers more flexible product assessment while ensuring compliance and data quality.
We introduce the first automation platform for cytotoxicity assays, fully validated and interfaced with internal data management systems. The prototype's modular design allows for easy expansion, including additional assessments and upstream sample processing. This marks a crucial step towards fully automating and digitalizing product assessment in a highly regulated environment.
For conference production and speaking opportunites:
Für die Produktion von Konferenzen und die Möglichkeit, Vorträge zu halten:
For sponsorship and exhibition opportunities: